Timothy Siegert, PhD
COO, Allyx Therapeutics
A scientist and entrepreneur, Tim co-founded Allyx Therapeutics and serves as its Chief Operating Officer. Tim has led efforts across both Business Development and Research & Development, securing multiple grants and serving as the principal investigator of ongoing clinical research. Previous to his role at Allyx, Tim completed the Yale Blavatnik Fellowship for Entrepreneurship. While an inaugural Blavatnik Fellow at Yale, Tim worked within Yale’s Office of Cooperative Research (now Yale Ventures) to build and launch new biotech ventures from the Yale technology portfolio. Tim is a chemical biologist by training and prior to Yale held a scientist role at Ra Pharmaceuticals in Cambridge, MA. Tim holds a B.S. from Boston College and received his Ph.D. in chemistry from Tufts University.